Funding
← Back to your selection

Point72

Activity from announced rounds

Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$1.3B
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech1
Climate tech1

By country

United States2

Rounds

2 in this selection
Valar Atomics

Valar Atomics develops modular nuclear reactors and energy campuses for industrial heat and electricity.

$1BSeries B
Participant
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed